Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[pool]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[ancestry category]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[sex]	Characteristics[disease]	Characteristics[depletion]	Characteristics[individual]	assay name	comment[fractionation method]	comment[fraction identifier]	comment[file uri]	comment[instrument]	comment[separation]	comment[label]	comment[cleavage agent details]	comment[modification parameters]	comment[dissociation method]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	Material Type	Factor value[pool]
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 1	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx01.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 2	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx01.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 3	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx01.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 4	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx01.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 5	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx01.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 6	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx01.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 7	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx02.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 8	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx02.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 9	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx02.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 10	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx02.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 11	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx02.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 12	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx02.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 13	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx03.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 14	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx03.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 15	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx03.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 16	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx03.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 17	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx03.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 18	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx03.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 19	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx04.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 20	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx04.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 21	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx04.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 22	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx04.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 23	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx04.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 24	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx04.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 25	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx05.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 26	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx05.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 27	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx05.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 28	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx05.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 29	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx05.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 30	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx05.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 31	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx06.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 32	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx06.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 33	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx06.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 34	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx06.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 35	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx06.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 36	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx06.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 37	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx07.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 38	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx07.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 39	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx07.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 40	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx07.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 41	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx07.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 42	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx07.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 43	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx08.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 44	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx08.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 45	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx08.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 46	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx08.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 47	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx08.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 48	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx08.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 49	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx09.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 50	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx09.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 51	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx09.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 52	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx09.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 53	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx09.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 54	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx09.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 55	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx10.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 56	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx10.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 57	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx10.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 58	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx10.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 59	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx10.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 60	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx10.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 61	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx11.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 62	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx11.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 63	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx11.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 64	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx11.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 65	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx11.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 66	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx11.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 67	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx12.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 68	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx12.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 69	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx12.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 70	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx12.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 71	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx12.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 72	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx12.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 73	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx13.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 74	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx13.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 75	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx13.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 76	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx13.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 77	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx13.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 78	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx13.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 79	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx14.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 80	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx14.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 81	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx14.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 82	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx14.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 83	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx14.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 84	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx14.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 85	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx15.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 86	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx15.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 87	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx15.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 88	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx15.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 89	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx15.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 90	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx15.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 91	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx16.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 92	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx16.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 93	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx16.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 94	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx16.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 95	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx16.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 96	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx16.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 97	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx17.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 98	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx17.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 99	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx17.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 100	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx17.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 101	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx17.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 102	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx17.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 103	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx18.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 104	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx18.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 105	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx18.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 106	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx18.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 107	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx18.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 108	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx18.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 109	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx19.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 110	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx19.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 111	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx19.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 112	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx19.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 113	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx19.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 114	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx19.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 115	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx20.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 116	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx20.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 117	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx20.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 118	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx20.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 119	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx20.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 120	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx20.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 121	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx21.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 122	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx21.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 123	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx21.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 124	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx21.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 125	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx21.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 126	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx21.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 127	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx22.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 128	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx22.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 129	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx22.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 130	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx22.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 131	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx22.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 132	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx22.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 133	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx23.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 134	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx23.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 135	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx23.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 136	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx23.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 137	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx23.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 138	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx23.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 139	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx24.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 140	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx24.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 141	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx24.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 142	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx24.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 143	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx24.raw	tissue	1
Sample 1	Homo sapiens	cerebrospinal fluid	1	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 144	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch1_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch1_Fx24.raw	tissue	1
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 145	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx01.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 146	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx01.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 147	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx01.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 148	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx01.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 149	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx01.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 150	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx01.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 151	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx02.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 152	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx02.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 153	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx02.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 154	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx02.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 155	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx02.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 156	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx02.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 157	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx03.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 158	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx03.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 159	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx03.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 160	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx03.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 161	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx03.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 162	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx03.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 163	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx04.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 164	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx04.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 165	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx04.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 166	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx04.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 167	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx04.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 168	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx04.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 169	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx05.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 170	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx05.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 171	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx05.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 172	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx05.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 173	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx05.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 174	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx05.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 175	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx06.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 176	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx06.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 177	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx06.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 178	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx06.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 179	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx06.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 180	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx06.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 181	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx07.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 182	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx07.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 183	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx07.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 184	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx07.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 185	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx07.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 186	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx07.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 187	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx08.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 188	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx08.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 189	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx08.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 190	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx08.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 191	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx08.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 192	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx08.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 193	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx09.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 194	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx09.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 195	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx09.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 196	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx09.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 197	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx09.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 198	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx09.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 199	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx10.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 200	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx10.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 201	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx10.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 202	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx10.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 203	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx10.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 204	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx10.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 205	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx11.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 206	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx11.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 207	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx11.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 208	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx11.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 209	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx11.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 210	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx11.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 211	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx12.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 212	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx12.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 213	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx12.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 214	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx12.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 215	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx12.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 216	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx12.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 217	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx13.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 218	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx13.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 219	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx13.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 220	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx13.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 221	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx13.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 222	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx13.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 223	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx14.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 224	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx14.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 225	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx14.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 226	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx14.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 227	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx14.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 228	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx14.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 229	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx15.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 230	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx15.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 231	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx15.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 232	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx15.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 233	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx15.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 234	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx15.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 235	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx16.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 236	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx16.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 237	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx16.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 238	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx16.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 239	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx16.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 240	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx16.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 241	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx17.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 242	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx17.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 243	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx17.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 244	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx17.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 245	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx17.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 246	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx17.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 247	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx18.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 248	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx18.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 249	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx18.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 250	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx18.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 251	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx18.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 252	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx18.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 253	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx19.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 254	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx19.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 255	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx19.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 256	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx19.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 257	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx19.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 258	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx19.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 259	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx20.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 260	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx20.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 261	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx20.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 262	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx20.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 263	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx20.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 264	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx20.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 265	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx21.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 266	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx21.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 267	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx21.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 268	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx21.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 269	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx21.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 270	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx21.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 271	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx22.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 272	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx22.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 273	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx22.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 274	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx22.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 275	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx22.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 276	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx22.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 277	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx23.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 278	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx23.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 279	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx23.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 280	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx23.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 281	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx23.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 282	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx23.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 283	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx24.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 284	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx24.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 285	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx24.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 286	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx24.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 287	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx24.raw	tissue	2
Sample 2	Homo sapiens	cerebrospinal fluid	2	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 288	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch2_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch2_Fx24.raw	tissue	2
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 289	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx01.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 290	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx01.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 291	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx01.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 292	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx01.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 293	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx01.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 294	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx01.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 295	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx02.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 296	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx02.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 297	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx02.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 298	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx02.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 299	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx02.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 300	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx02.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 301	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx03.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 302	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx03.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 303	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx03.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 304	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx03.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 305	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx03.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 306	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx03.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 307	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx04.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 308	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx04.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 309	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx04.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 310	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx04.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 311	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx04.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 312	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx04.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 313	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx05.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 314	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx05.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 315	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx05.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 316	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx05.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 317	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx05.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 318	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx05.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 319	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx06.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 320	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx06.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 321	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx06.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 322	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx06.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 323	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx06.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 324	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx06.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 325	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx07.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 326	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx07.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 327	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx07.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 328	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx07.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 329	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx07.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 330	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx07.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 331	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx08.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 332	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx08.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 333	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx08.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 334	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx08.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 335	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx08.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 336	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx08.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 337	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx09.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 338	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx09.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 339	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx09.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 340	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx09.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 341	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx09.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 342	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx09.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 343	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx10.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 344	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx10.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 345	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx10.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 346	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx10.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 347	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx10.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 348	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx10.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 349	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx11.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 350	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx11.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 351	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx11.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 352	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx11.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 353	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx11.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 354	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx11.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 355	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx12.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 356	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx12.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 357	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx12.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 358	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx12.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 359	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx12.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 360	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx12.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 361	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx13.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 362	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx13.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 363	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx13.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 364	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx13.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 365	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx13.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 366	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx13.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 367	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 368	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 369	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 370	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 371	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 372	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx14.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 373	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 374	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 375	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 376	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 377	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 378	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx15.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 379	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 380	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 381	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 382	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 383	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 384	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx16.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 385	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 386	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 387	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 388	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 389	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 390	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx17.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 391	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 392	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 393	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 394	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 395	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 396	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx18.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 397	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 398	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 399	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 400	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 401	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 402	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx19.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 403	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx20.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 404	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx20.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 405	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx20.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 406	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx20.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 407	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx20.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 408	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx20.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 409	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx21.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 410	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx21.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 411	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx21.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 412	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx21.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 413	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx21.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 414	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx21.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 415	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx22.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 416	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx22.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 417	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx22.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 418	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx22.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 419	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx22.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 420	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx22.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 421	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx23.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 422	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx23.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 423	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx23.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 424	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx23.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 425	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx23.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 426	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx23.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 427	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx24.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 428	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx24.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient2	run 429	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx24.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	not available	leptomeningeal melanoma metastases	depletion	Patient7	run 430	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx24.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 431	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx24.raw	tissue	3
Sample 3	Homo sapiens	cerebrospinal fluid	3	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient6	run 432	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch3_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch3_Fx24.raw	tissue	3
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 433	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx01.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 434	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx01.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 435	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx01.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 436	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx01.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 437	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx01.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 438	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx01.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 439	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx02.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 440	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx02.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 441	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx02.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 442	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx02.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 443	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx02.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 444	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx02.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 445	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx03.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 446	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx03.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 447	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx03.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 448	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx03.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 449	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx03.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 450	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx03.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 451	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx04.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 452	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx04.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 453	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx04.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 454	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx04.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 455	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx04.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 456	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx04.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 457	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx05.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 458	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx05.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 459	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx05.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 460	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx05.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 461	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx05.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 462	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx05.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 463	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx06.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 464	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx06.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 465	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx06.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 466	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx06.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 467	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx06.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 468	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx06.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 469	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx07.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 470	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx07.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 471	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx07.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 472	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx07.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 473	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx07.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 474	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx07.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 475	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx08.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 476	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx08.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 477	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx08.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 478	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx08.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 479	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx08.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 480	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx08.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 481	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx09.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 482	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx09.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 483	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx09.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 484	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx09.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 485	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx09.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 486	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx09.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 487	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx10.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 488	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx10.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 489	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx10.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 490	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx10.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 491	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx10.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 492	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx10.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 493	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx11.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 494	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx11.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 495	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx11.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 496	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx11.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 497	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx11.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 498	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx11.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 499	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx12.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 500	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx12.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 501	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx12.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 502	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx12.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 503	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx12.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 504	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx12.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 505	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx13.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 506	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx13.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 507	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx13.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 508	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx13.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 509	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx13.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 510	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx13.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 511	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx14.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 512	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx14.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 513	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx14.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 514	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx14.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 515	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx14.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 516	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx14.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 517	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx15.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 518	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx15.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 519	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx15.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 520	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx15.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 521	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx15.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 522	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx15.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 523	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx16.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 524	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx16.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 525	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx16.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 526	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx16.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 527	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx16.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 528	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx16.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 529	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 530	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 531	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 532	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 533	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 534	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx17.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 535	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 536	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 537	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 538	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 539	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 540	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx18.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 541	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 542	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 543	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 544	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 545	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 546	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx19.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 547	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 548	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 549	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 550	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 551	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 552	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx20.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 553	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 554	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 555	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 556	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 557	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 558	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx21.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 559	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 560	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 561	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 562	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 563	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 564	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx22.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 565	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx23.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 566	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx23.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 567	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx23.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 568	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx23.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 569	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx23.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 570	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx23.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 571	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx24.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 572	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx24.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 573	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx24.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 574	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx24.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 575	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx24.raw	tissue	4
Sample 4	Homo sapiens	cerebrospinal fluid	4	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 576	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch4_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch4_Fx24.raw	tissue	4
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 577	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx01.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 578	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx01.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 579	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx01.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 580	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx01.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 581	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx01.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 582	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx01.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 583	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx02.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 584	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx02.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 585	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx02.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 586	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx02.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 587	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx02.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 588	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx02.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 589	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx03.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 590	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx03.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 591	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx03.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 592	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx03.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 593	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx03.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 594	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx03.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 595	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx04.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 596	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx04.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 597	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx04.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 598	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx04.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 599	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx04.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 600	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx04.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 601	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx05.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 602	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx05.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 603	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx05.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 604	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx05.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 605	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx05.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 606	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx05.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 607	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx06.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 608	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx06.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 609	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx06.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 610	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx06.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 611	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx06.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 612	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx06.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 613	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx07.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 614	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx07.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 615	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx07.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 616	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx07.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 617	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx07.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 618	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx07.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 619	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx08.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 620	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx08.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 621	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx08.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 622	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx08.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 623	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx08.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 624	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx08.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 625	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx09.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 626	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx09.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 627	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx09.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 628	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx09.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 629	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx09.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 630	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx09.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 631	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx10.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 632	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx10.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 633	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx10.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 634	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx10.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 635	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx10.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 636	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx10.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 637	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx11.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 638	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx11.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 639	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx11.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 640	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx11.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 641	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx11.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 642	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx11.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 643	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx12.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 644	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx12.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 645	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx12.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 646	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx12.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 647	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx12.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 648	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx12.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 649	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx13.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 650	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx13.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 651	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx13.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 652	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx13.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 653	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx13.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 654	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx13.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 655	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx14.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 656	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx14.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 657	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx14.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 658	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx14.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 659	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx14.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 660	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx14.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 661	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx15.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 662	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx15.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 663	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx15.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 664	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx15.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 665	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx15.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 666	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx15.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 667	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx16.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 668	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx16.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 669	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx16.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 670	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx16.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 671	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx16.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 672	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx16.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 673	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx17.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 674	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx17.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 675	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx17.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 676	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx17.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 677	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx17.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 678	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx17.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 679	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx18.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 680	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx18.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 681	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx18.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 682	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx18.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 683	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx18.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 684	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx18.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 685	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx19.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 686	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx19.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 687	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx19.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 688	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx19.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 689	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx19.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 690	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx19.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 691	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx20.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 692	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx20.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 693	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx20.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 694	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx20.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 695	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx20.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 696	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx20.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 697	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx21.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 698	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx21.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 699	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx21.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 700	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx21.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 701	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx21.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 702	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx21.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 703	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx22.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 704	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx22.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 705	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx22.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 706	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx22.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 707	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx22.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 708	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx22.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 709	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx23.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 710	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx23.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 711	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx23.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 712	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx23.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 713	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx23.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 714	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx23.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 715	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx24.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient3	run 716	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx24.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	female	leptomeningeal melanoma metastases	depletion	Patient1	run 717	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx24.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 718	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx24.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient4	run 719	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx24.raw	tissue	5
Sample 5	Homo sapiens	cerebrospinal fluid	5	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient9	run 720	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch5_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch5_Fx24.raw	tissue	5
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 721	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx01.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 722	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx01.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 723	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx01.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 724	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx01.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 725	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx01.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 726	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx01.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 727	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx02.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 728	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx02.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 729	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx02.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 730	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx02.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 731	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx02.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 732	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx02.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 733	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx03.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 734	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx03.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 735	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx03.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 736	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx03.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 737	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx03.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 738	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx03.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 739	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx04.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 740	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx04.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 741	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx04.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 742	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx04.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 743	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx04.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 744	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx04.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 745	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx05.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 746	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx05.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 747	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx05.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 748	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx05.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 749	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx05.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 750	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx05.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 751	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx06.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 752	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx06.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 753	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx06.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 754	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx06.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 755	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx06.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 756	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx06.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 757	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx07.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 758	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx07.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 759	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx07.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 760	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx07.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 761	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx07.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 762	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx07.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 763	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx08.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 764	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx08.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 765	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx08.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 766	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx08.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 767	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx08.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 768	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx08.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 769	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx09.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 770	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx09.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 771	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx09.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 772	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx09.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 773	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx09.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 774	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx09.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 775	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx10.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 776	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx10.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 777	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx10.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 778	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx10.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 779	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx10.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 780	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx10.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 781	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx11.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 782	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx11.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 783	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx11.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 784	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx11.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 785	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx11.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 786	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx11.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 787	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx12.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 788	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx12.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 789	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx12.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 790	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx12.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 791	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx12.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 792	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx12.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 793	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx13.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 794	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx13.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 795	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx13.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 796	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx13.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 797	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx13.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 798	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx13.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 799	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx14.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 800	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx14.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 801	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx14.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 802	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx14.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 803	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx14.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 804	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx14.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 805	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx15.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 806	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx15.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 807	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx15.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 808	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx15.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 809	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx15.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 810	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx15.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 811	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx16.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 812	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx16.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 813	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx16.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 814	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx16.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 815	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx16.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 816	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx16.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 817	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx17.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 818	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx17.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 819	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx17.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 820	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx17.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 821	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx17.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 822	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx17.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 823	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx18.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 824	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx18.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 825	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx18.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 826	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx18.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 827	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx18.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 828	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx18.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 829	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx19.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 830	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx19.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 831	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx19.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 832	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx19.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 833	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx19.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 834	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx19.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 835	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx20.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 836	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx20.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 837	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx20.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 838	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx20.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 839	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx20.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 840	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx20.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 841	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx21.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 842	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx21.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 843	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx21.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 844	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx21.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 845	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx21.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 846	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx21.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 847	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx22.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 848	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx22.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 849	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx22.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 850	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx22.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 851	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx22.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 852	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx22.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 853	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx23.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 854	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx23.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 855	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx23.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 856	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx23.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 857	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx23.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 858	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx23.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 859	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx24.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 860	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx24.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 861	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx24.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 862	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx24.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 863	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx24.raw	tissue	6
Sample 6	Homo sapiens	cerebrospinal fluid	6	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient5	run 864	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch6_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch6_Fx24.raw	tissue	6
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 865	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx01.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 866	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx01.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 867	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx01.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 868	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx01.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 869	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx01.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 870	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx01.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx01.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 871	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx02.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 872	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx02.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 873	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx02.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 874	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx02.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 875	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx02.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 876	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	2	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx02.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx02.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 877	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx03.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 878	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx03.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 879	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx03.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 880	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx03.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 881	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx03.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 882	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	3	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx03.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx03.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 883	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx04.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 884	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx04.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 885	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx04.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 886	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx04.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 887	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx04.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 888	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	4	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx04.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx04.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 889	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx05.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 890	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx05.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 891	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx05.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 892	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx05.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 893	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx05.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 894	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	5	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx05.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx05.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 895	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx06.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 896	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx06.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 897	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx06.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 898	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx06.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 899	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx06.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 900	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	6	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx06.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx06.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 901	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx07.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 902	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx07.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 903	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx07.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 904	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx07.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 905	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx07.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 906	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx07.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx07.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 907	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx08.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 908	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx08.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 909	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx08.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 910	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx08.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 911	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx08.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 912	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	8	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx08.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx08.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 913	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx09.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 914	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx09.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 915	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx09.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 916	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx09.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 917	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx09.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 918	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	9	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx09.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx09.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 919	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx10.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 920	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx10.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 921	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx10.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 922	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx10.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 923	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx10.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 924	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	10	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx10.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx10.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 925	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx11.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 926	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx11.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 927	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx11.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 928	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx11.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 929	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx11.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 930	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	11	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx11.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx11.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 931	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx12.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 932	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx12.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 933	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx12.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 934	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx12.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 935	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx12.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 936	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	12	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx12.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx12.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 937	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx13.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 938	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx13.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 939	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx13.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 940	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx13.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 941	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx13.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 942	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	13	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx13.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx13.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 943	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx14.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 944	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx14.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 945	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx14.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 946	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx14.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 947	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx14.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 948	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	14	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx14.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx14.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 949	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx15.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 950	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx15.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 951	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx15.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 952	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx15.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 953	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx15.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 954	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	15	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx15.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx15.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 955	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx16.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 956	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx16.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 957	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx16.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 958	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx16.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 959	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx16.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 960	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	16	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx16.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx16.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 961	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx17.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 962	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx17.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 963	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx17.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 964	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx17.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 965	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx17.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 966	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	17	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx17.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx17.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 967	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx18.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 968	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx18.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 969	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx18.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 970	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx18.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 971	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx18.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 972	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	18	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx18.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx18.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 973	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx19.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 974	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx19.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 975	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx19.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 976	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx19.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 977	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx19.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 978	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	19	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx19.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx19.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 979	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx20.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 980	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx20.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 981	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx20.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 982	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx20.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 983	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx20.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 984	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	20	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx20.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx20.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 985	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx21.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 986	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx21.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 987	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx21.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 988	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx21.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 989	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx21.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 990	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx21.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx21.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 991	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx22.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 992	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx22.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 993	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx22.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 994	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx22.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 995	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx22.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 996	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	22	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx22.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx22.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 997	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx23.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 998	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx23.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 999	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx23.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1000	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx23.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1001	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx23.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1002	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	23	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx23.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx23.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	not applicable	normal	depletion	Pool	run 1003	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT126	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx24.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1004	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT127	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx24.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1005	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT128	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx24.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1006	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT129	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx24.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1007	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT130	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx24.raw	tissue	7
Sample 7	Homo sapiens	cerebrospinal fluid	7	not available	not available	not available	not applicable	not applicable	male	leptomeningeal melanoma metastases	depletion	Patient8	run 1008	NT=Reversed-phase chromatography (RP);AC=PRIDE:0000563	24	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/01/PXD016002/20171207_Inna-CSF_TMTBatch7_Fx24.raw	NT=Q Exactive Plus;AC=MS:1002634	AC=PRIDE:0000563;NT=Reversed-phase chromatography	TMT131	AC=MS:1001251;NT=Trypsin	not available	not available	not available	not available	20171207_Inna-CSF_TMTBatch7_Fx24.raw	tissue	7
